Drug Shortage Report for IMITREX DF - TAB 50MG
Report ID | 214042 |
Drug Identification Number | 02212153 |
Brand name | IMITREX DF - TAB 50MG |
Common or Proper name | Sumatriptan succinate tablets |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | SUMATRIPTAN |
Strength(s) | 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 6s |
ATC code | N02CC |
ATC description | ANTIMIGRAINE PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-12-21 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-10-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-12-22 | English | Compare |
v2 | 2023-12-22 | French | Compare |
v3 | 2024-04-01 | English | Compare |
v4 | 2024-04-01 | French | Compare |
v5 | 2024-07-02 | English | Compare |
v6 | 2024-07-02 | French | Compare |
v7 | 2024-10-02 | English | Compare |
v8 | 2024-10-02 | French | Compare |
Showing 1 to 8 of 8